Target intelligence / Profile preview

Calmin (CLMN)

Target
CLMN
Molecular classification
Other (calponin homology domain-containing protein), Cytoskeleton-associated protein, ER-membrane associated protein
01

Overview

Calmin (CLMN) is a single-pass type IV transmembrane protein containing calponin homology domains, primarily localized to the endoplasmic reticulum (ER) tubules where it functions as an ER–actin molecular tether[3][1]. CLMN anchors ER tubules to actin cytoskeletal structures (notably at focal adhesions), facilitating adhesion disassembly and cell motility[1]. Its actin-regulating domains are required for actin association, while its transmembrane region is required for ER localization. Loss of CLMN affects actin organization, impairs focal adhesion turnover, and disrupts cell migration. In addition to roles in cytoskeletal dynamics, CLMN has been associated with cell cycle exit during neuronal differentiation, suggesting possible tissue-specific functions. No direct links to therapeutic targeting, interacting drugs, biomarker utility, or safety concerns are currently reported for this protein[1][3].

Other names
CalminCLMNKIAA1188FLJ12383KIAA0500Calponin-like transmembrane domain proteincalponin-like transmembrane domain protein
02

Biological functions

Actin filament bindingRegulation of actin dynamicsNegative regulation of cell proliferationRegulation of focal adhesion disassemblyRegulation of cell migrationER–cytoskeleton tetheringRegulation of local calcium signaling
03

Disease associations

Other (limited evidence for direct disease association; potential in neurodevelopment/differentiation[1])

Beyond the preview

Go deeper on Calmin (CLMN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmin (CLMN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call